NCT04781452 Evaluating the Treatment in the MZEB Aachen
| NCT ID | NCT04781452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RWTH Aachen University |
| Condition | Intellectual Disability |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2019-07-01 |
| Primary Completion | 2029-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2019-07-01 with a primary completion date of 2029-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of patient characteristics, involved physicians and therapists as well as therapies in a German University Center for the Treatment of patients with intellectual disabilities and severe multiple disability (MZEB Aachen)
Eligibility Criteria
Inclusion Criteria: * intellectual disability and/or severe multiple disability (disability degree GdB at least 70 and at least one noticeable sign * willing to participate Exclusion Criteria: * housed in an Institution and/or prison
Contact & Investigator
Jörg B Schulz, MD
STUDY CHAIR
RWTH Aachen University
Frequently Asked Questions
Who can join the NCT04781452 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Intellectual Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04781452 currently recruiting?
Yes, NCT04781452 is actively recruiting participants. Contact the research team at mzeb@ukaachen.de for enrollment information.
Where is the NCT04781452 trial being conducted?
This trial is being conducted at Aachen, Germany.
Who is sponsoring the NCT04781452 clinical trial?
NCT04781452 is sponsored by RWTH Aachen University. The principal investigator is Jörg B Schulz, MD at RWTH Aachen University. The trial plans to enroll 2,000 participants.